reports
- Expert Corporate Governance Service (ECGS)
Etude de l'AG du 04/05/2017
HS controversy:In 2011, the Korean Centre for Disease Control (KCDC) determined that Oxy RB’s (the Company’s Korean subsidiary) humidifier sanitiser (HS) products might have been responsible for serious respiratory diseases, including fatalities (about 100) dating back to 2001. After charges were brought against the Company by the Korean government, it decided to defend itself in court and subsequently settled 63 of 79 cases brought by Category I and II Oxy HS victims through to March 2016. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.